Dec 16, 2022 | Sheri Baker
Three years ago, when I attended the American Society of Hematology (ASH) Annual Meeting, the darling of the dance was Darzalex® (daratumumab). They combined Darzalex® with everything and with great results. The past couple of years CAR-T therapy took over as the most...
Dec 16, 2022 | Robin Tuohy
Heads up: this blog will not contain any specific abstract information, but rather to give you a bit of history and flavor of the daily schedules for leaders volunteering their time selflessly to bring you their patient perspectives. Please read their blogs for...
Dec 16, 2022 | Michael Tuohy
I appreciate that there are abstracts that are looking for data regarding lower / no dex. Dr. Mikhael paints a great picture of how dex could be used like a rocket booster on a spaceship. When the spaceship first takes off, it needs the power of rocket boosters to...
Dec 16, 2022 | Jack Aiello
PREFACE This is my 17th year attending American Society of Hematology (ASH) Annual Meeting, where typically over 30,000 attendees from all over the world (hematologists/oncologists, lab researchers, oncology nurses, scientists, and 300 pharma companies) attend. This...
Dec 14, 2022 | Becky Bosley
Another ASH comes to a close, and yet again, I am energized and exhausted, simultaneously! Our virtual experience was 10-16 hours a day for 4 days straight, including all of the oral abstract presentations, poster sessions, educational sessions, and working group...
Dec 14, 2022 | John DeFlice
“Alone, we can do so little; together, we can do so much.” Helen Keller I am fortunate to have attended The American Society of Hematology (ASH) 2022 Annual Meeting in New Orleans. Although I attended virtually, it did not diminish the opportunity to observe themany...
